Artelo Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARTL and other ETFs, options, and stocks.

About ARTL

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. 

CEO
Gregory D. Gorgas
CEOGregory D. Gorgas
Employees
7
Employees7
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2011
Founded2011
Employees
7
Employees7

ARTL Key Statistics

Market cap
4.81M
Market cap4.81M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
5.01M
Average volume5.01M
High today
$1.43
High today$1.43
Low today
$1.35
Low today$1.35
Open price
$1.39
Open price$1.39
Volume
287.51K
Volume287.51K
52 Week high
$85.80
52 Week high$85.80
52 Week low
$1.19
52 Week low$1.19

Stock Snapshot

With a market cap of 4.81M, Artelo Biosciences(ARTL) trades at $1.35. The stock has a price-to-earnings ratio of -0.04.

During the trading session on 2026-06-05, Artelo Biosciences(ARTL) shares reached a daily high of $1.43 and a low of $1.35. At a current price of $1.35, the stock is +0.0% higher than the low and still -5.5% under the high.

Trading volume for Artelo Biosciences(ARTL) stock has reached 287.51K, versus its average volume of 5.01M.

The stock's 52-week range extends from a low of $1.19 to a high of $85.80.

The stock's 52-week range extends from a low of $1.19 to a high of $85.80.

People also own

Based on the portfolios of people who own ARTL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.